Global Forum on Nicotine (GFN22)

      Date
      Jun 16, 2022 - Jun 18, 2022
      Location
      Warsaw, Poland/Virtual

      The Global Forum on Nicotine (GFN) is an international conference to focus on the role of safer nicotine products that help people switch from smoking. Safer nicotine products include e-cigarettes (vapes), nicotine pouches, oral tobaccos such as Swedish snus, and heated tobacco products. This is a rapidly evolving area, with many new non-combustible products emerging over the past ten to fifteen years. The GFN examines the rapidly developing science in relation to nicotine and its use, including policy and regulatory responses. The conference this year is themed 'Tobacco harm reduction - here for good.'

      Go to the conference website: https://gfn.events/

      Watch presenters from PMI: 

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.